The Darkness and the Chainsmokers

The Chainsmokers are a duo that consists of Alex Pall as well as Andrew Taggart. They had their first breakthrough hit with the song #Selfie, in 2014. This song became a top 20 single in quite a few countries and helped the duo achieve worldwide recognition. And after that, it was just all uphill from there. They were on their way to great success. Even though it might seem that they have been around for a bit, it is really only about 2 years since they have started seeing the joys of success.

Their next hit was the song “Roses” and from there they have been unstoppable. Then came the hit songs “Paris,” “Something Just Like This” which they did with Coldplay. Then the “Closer” with Halsey which was number one for twelve weeks, and the Grammy-winning song “Don’t Let Me Down,”. This song also featured Daya, a relative newcomer to the music business.

With this type of success, they might have been tempted to continue with the type of music that had gotten them to this point. Indeed, most musical groups would have, but not this group, they decided that they wanted a challenge. They changed their sound slightly, to what they consider to be a little bit darker. So along came the single “Sick Boy” which has a bit of a different sound. The video has been described as visually stunning as well. With this new twist on a sound, they are onto the next phase of their new success.

The Chainsmokers like to think that their music reflects society and their generation. They discussed that as being the reason that their new sound in music has changed a bit. They feel that the tone in society recently has been more along the dark side and that their music is just a reflection of this. They also feel that their frustration with how they might be portrayed, incorrectly in the media, was another deciding factor in how their new sound came about. They channeled their frustration about this and their anger into their new sound. It seems to be working very well for them.

https://www.pandora.com/artist/the-chainsmokers/ARXX6jwckzwk4nw

The Science of Scott Rocklage and Building Businesses

Renowned scientist and entrepreneur Scott Rocklage is a rare breed. He has found success through boldly seeking out business ventures in his career. However, his background in the sciences allows him to take measured risk, either related to inventing a new patent or managing on his portfolio companies. Through education and leadership, Rocklage has found his niche in the healthcare investment market. Read more: Scott Racklage | Crunchbase

Throughout the years, Scott Rocklage has held numerous high-ranking positions at different companies. Rocklage was involved in research and development of new medications at multiple corporations, including Catalytica and Salutar.

He was also the President and CEO of Cubist Pharmaceuticals for a period of time, as well as serving on the board for Novira and Relypsa. Scott Rocklage was integral in the approval of three new medications by the FDA. His work included finding qualified candidates for clinical trials.

Scott Rocklage is now a Managing Partner of 5AM Ventures, a capital investment firm that specializes in growing other businesses in the area of life sciences.

Rocklage joined the 5AM team as a Venture Partner in 2003 and became a Managing partner only a year later. Currently, Rocklage is based out of the offices he runs in Boston, Massachusetts. He has over three decades of experience in the healthcare industry.

Prior to his career, Scott Rocklage attended the University of California at Berkeley. He graduated from UC Berkeley with a Bachelor of Science degree in Chemistry. Rocklage also attended the Massachusetts Institute of Technology. He completed his studies at MIT and was given his Ph.D. in Chemistry. Scott Rocklage regularly studies advances in research to expand his knowledge in his own free time. His specific focus is the area of life science.

Scott Rocklage has an impressive list of accomplishments in the scientific field. He has published over 100 technical articles that have been reviewed by peers. Rocklage was also the sole inventor or co-inventor behind more than 30 patents that are registered within the United States. His experience stems from performing research in the laboratory of Richard R Schrock, a recipient of the Nobel Prize for Chemistry in 2005.